MA49526A - Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco - Google Patents
Chimiothérapie anticancéreuse mettant en uvre un composé azabicycoInfo
- Publication number
- MA49526A MA49526A MA049526A MA49526A MA49526A MA 49526 A MA49526 A MA 49526A MA 049526 A MA049526 A MA 049526A MA 49526 A MA49526 A MA 49526A MA 49526 A MA49526 A MA 49526A
- Authority
- MA
- Morocco
- Prior art keywords
- azabicyco
- compound
- cancer chemotherapy
- chemotherapy
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017128823 | 2017-06-30 | ||
JP2017177390 | 2017-09-15 | ||
JP2018099931 | 2018-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA49526A true MA49526A (fr) | 2021-03-24 |
Family
ID=64741994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA049526A MA49526A (fr) | 2017-06-30 | 2018-06-29 | Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200129487A1 (fr) |
EP (1) | EP3646869A4 (fr) |
JP (2) | JP7264812B2 (fr) |
KR (1) | KR102599698B1 (fr) |
CN (1) | CN110831594A (fr) |
AU (1) | AU2018291366B2 (fr) |
BR (1) | BR112019028226A2 (fr) |
CA (1) | CA3068580A1 (fr) |
MA (1) | MA49526A (fr) |
MX (1) | MX2020000150A (fr) |
WO (1) | WO2019004417A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3068580A1 (fr) * | 2017-06-30 | 2019-01-03 | Taiho Pharmaceutical Co., Ltd. | Chimiotherapie anticancereuse mettant en oeuvre un compose azabicyco |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2206517B1 (fr) | 2002-07-03 | 2023-08-02 | Ono Pharmaceutical Co., Ltd. | Compositions immunostimulantes contenant un anticorps anti-PD-L1 |
AU2010269674B2 (en) | 2009-07-10 | 2014-01-16 | Taiho Pharmaceutical Co., Ltd. | Azabicyclo compound and salt thereof |
ES2848706T3 (es) * | 2013-09-30 | 2021-08-11 | Taiho Pharmaceutical Co Ltd | Terapia de combinación contra el cáncer usando un compuesto azabicíclico |
CN107645957A (zh) * | 2015-02-09 | 2018-01-30 | 辛塔制药公司 | 治疗癌症的hsp90抑制剂和pd‑1抑制剂的组合疗法 |
CA3068580A1 (fr) * | 2017-06-30 | 2019-01-03 | Taiho Pharmaceutical Co., Ltd. | Chimiotherapie anticancereuse mettant en oeuvre un compose azabicyco |
-
2018
- 2018-06-29 CA CA3068580A patent/CA3068580A1/fr active Pending
- 2018-06-29 US US16/627,146 patent/US20200129487A1/en active Pending
- 2018-06-29 MX MX2020000150A patent/MX2020000150A/es unknown
- 2018-06-29 JP JP2019527053A patent/JP7264812B2/ja active Active
- 2018-06-29 KR KR1020197036672A patent/KR102599698B1/ko active IP Right Grant
- 2018-06-29 AU AU2018291366A patent/AU2018291366B2/en active Active
- 2018-06-29 MA MA049526A patent/MA49526A/fr unknown
- 2018-06-29 BR BR112019028226-2A patent/BR112019028226A2/pt unknown
- 2018-06-29 CN CN201880044035.1A patent/CN110831594A/zh active Pending
- 2018-06-29 WO PCT/JP2018/024776 patent/WO2019004417A1/fr active Application Filing
- 2018-06-29 EP EP18825157.3A patent/EP3646869A4/fr active Pending
-
2021
- 2021-03-09 JP JP2021036843A patent/JP7319314B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
RU2020103758A (ru) | 2021-07-30 |
US20200129487A1 (en) | 2020-04-30 |
JPWO2019004417A1 (ja) | 2020-05-21 |
JP7264812B2 (ja) | 2023-04-25 |
MX2020000150A (es) | 2020-07-22 |
EP3646869A4 (fr) | 2021-03-24 |
RU2020103758A3 (fr) | 2021-10-22 |
BR112019028226A2 (pt) | 2020-07-07 |
KR20200021464A (ko) | 2020-02-28 |
AU2018291366B2 (en) | 2022-10-27 |
CN110831594A (zh) | 2020-02-21 |
JP2021098726A (ja) | 2021-07-01 |
EP3646869A1 (fr) | 2020-05-06 |
JP7319314B2 (ja) | 2023-08-01 |
WO2019004417A1 (fr) | 2019-01-03 |
CA3068580A1 (fr) | 2019-01-03 |
AU2018291366A1 (en) | 2020-01-23 |
KR102599698B1 (ko) | 2023-11-07 |
TW201904573A (zh) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA47433A (fr) | Composé de quinazoline | |
DK3565712T3 (da) | Forbedringer til additiv fremstilling | |
DK3360864T3 (da) | Pyrimidinforbindelse | |
MA45940A (fr) | Composé hétérocyclique | |
DK3519398T3 (da) | Pyridinforbindelse | |
DK3298027T3 (da) | Anthelmintiske depsipeptidforbindelser | |
DK3186244T3 (da) | Dioxolananaloger af uridin til behandling af cancer | |
DK3612519T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
DK3271435T3 (da) | Sammensatte søjlestrukturer | |
MA50093A (fr) | Composé pentacyclique | |
DK3615544T3 (da) | Antitumorforbindelser | |
MA43275A (fr) | Composé de pyranodipyridine | |
DE112017003214A5 (de) | Bohrwerkzeug | |
MA45090A (fr) | Compositions anticancéreuses | |
DK3475522T3 (da) | Brøndboringssystem | |
DK3347403T3 (da) | Polyalkoxyfedtforbindelse | |
DK3256690T3 (da) | Brøndboringsindsprøjtningssystem | |
IL253276A0 (en) | Anticancer compounds | |
MA49880A (fr) | Composés anticancéreux | |
DK3672941T3 (da) | Pyridylpyridonforbindelser | |
DK3173531T3 (da) | Indretning til jordundersøgelse | |
IT201600102119A1 (it) | Seminatrice | |
DK3630729T3 (da) | Pyrimidinforbindelse | |
MA49526A (fr) | Chimiothérapie anticancéreuse mettant en uvre un composé azabicyco | |
EP3298005C0 (fr) | Composés anti-cancereux |